Shreyash Devalkar of Axis Mutual Fund advises careful investment. Pharma faces neutral impact from US tariffs. IT sector experiences global valuation reset. Defence shows growth due to scarcity premium. IPO boom signals market diversification. Consumption focuses on GST cuts and festive season. Market awaits earnings recovery into 2025. Investors should track earnings sustainability beyond festive demand.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets